187 related articles for article (PubMed ID: 33190027)
1. Value of dynamic contrast-enhanced magnetic resonance imaging for determining the plasma Epstein-Barr virus status and staging of nasopharyngeal carcinoma.
Sriyook A; Lertbutsayanukul C; Jittapiromsak N
Clin Imaging; 2021 Apr; 72():1-7. PubMed ID: 33190027
[TBL] [Abstract][Full Text] [Related]
2. Quantitative Analysis of DCE-MRI and RESOLVE-DWI for Differentiating Nasopharyngeal Carcinoma from Nasopharyngeal Lymphoid Hyperplasia.
Yu JY; Zhang D; Huang XL; Ma J; Yang C; Li XJ; Xiong H; Zhou B; Liao RK; Tang ZY
J Med Syst; 2020 Feb; 44(4):75. PubMed ID: 32103352
[TBL] [Abstract][Full Text] [Related]
3. [Relationship between parameters of dynamic contrast-enhanced MRI and clinical stage of nasopharyngeal carcinoma].
Yu X; Li F; Hu Y; Lu Q; Wang H
Zhonghua Zhong Liu Za Zhi; 2015 Aug; 37(8):597-602. PubMed ID: 26714600
[TBL] [Abstract][Full Text] [Related]
4. Value of Diffusion-Weighted Imaging and Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Prediction of Treatment Outcomes in Nasopharyngeal Carcinoma.
Paprad T; Lertbutsayanukul C; Jittapiromsak N
J Comput Assist Tomogr; 2022 Jul-Aug 01; 46(4):664-672. PubMed ID: 35483078
[TBL] [Abstract][Full Text] [Related]
5. The therapeutic utility of combining dynamic contrast-enhanced magnetic resonance imaging with arterial spin labeling in the staging of nasopharyngeal carcinoma.
Li H; Gong G; Wang L; Su Y; Lu J; Yin Y
BMC Med Imaging; 2023 May; 23(1):61. PubMed ID: 37138205
[TBL] [Abstract][Full Text] [Related]
6. DCE-MRI assessment of the effect of Epstein-Barr virus-encoded latent membrane protein-1 targeted DNAzyme on tumor vasculature in patients with nasopharyngeal carcinomas.
Liao WH; Yang LF; Liu XY; Zhou GF; Jiang WZ; Hou BL; Sun LQ; Cao Y; Wang XY
BMC Cancer; 2014 Nov; 14():835. PubMed ID: 25407966
[TBL] [Abstract][Full Text] [Related]
7. Dynamic contrast-enhanced MRI predicts PTEN protein expression which can function as a prognostic measure of progression-free survival in NPC patients.
Wu G; Huang W; Xu J; Li W; Wu Y; Yang Q; Liu K; Zhu M; Balasubramanian PS; Li M
J Cancer Res Clin Oncol; 2022 Jul; 148(7):1771-1780. PubMed ID: 34398299
[TBL] [Abstract][Full Text] [Related]
8. Dynamic contrast-enhanced MRI of nasopharyngeal carcinoma: correlation of quantitative dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) parameters with hypoxia-inducible factor 1α expression and tumor grade/stage.
Liu L; Hu L; Zeng Q; Peng D; Chen Z; Huang C; Liu Z; Wen Q; Zou F; Yan L
Ann Palliat Med; 2021 Feb; 10(2):2238-2253. PubMed ID: 33725777
[TBL] [Abstract][Full Text] [Related]
9. Nasopharyngeal carcinoma perfusion MRI: Comparison of arterial spin labeling and dynamic contrast-enhanced MRI.
Xiao B; Wang P; Zhao Y; Liu Y; Ye Z
Medicine (Baltimore); 2020 May; 99(22):e20503. PubMed ID: 32481470
[TBL] [Abstract][Full Text] [Related]
10. Dynamic contrast-enhanced MRI of nasopharyngeal carcinoma: a preliminary study of the correlations between quantitative parameters and clinical stage.
Zheng D; Chen Y; Chen Y; Xu L; Chen W; Yao Y; Du Z; Deng X; Chan Q
J Magn Reson Imaging; 2014 Apr; 39(4):940-8. PubMed ID: 24108569
[TBL] [Abstract][Full Text] [Related]
11. Intravoxel incoherent motion MR imaging in nasopharyngeal carcinoma: comparison and correlation with dynamic contrast enhanced MR imaging.
Lai V; Lee VHF; Lam KO; Huang B; Chan Q; Khong PL
Oncotarget; 2017 Sep; 8(40):68472-68482. PubMed ID: 28978131
[TBL] [Abstract][Full Text] [Related]
12. Individualized concurrent chemotherapy by pretreatment plasma Epstein-Barr viral DNA in II-III stage nasopharyngeal carcinoma: A propensity score matching analysis using a large cohort.
Sun XS; Chen WH; Liu SL; Liang YJ; Chen QY; Guo SS; Wen YF; Liu LT; Xie HJ; Tang QN; Li XY; Yan JJ; Mai HQ; Tang LQ
Cancer Med; 2019 Aug; 8(9):4214-4225. PubMed ID: 31210417
[TBL] [Abstract][Full Text] [Related]
13. Prognostic values of the integrated model incorporating the volume of metastatic regional cervical lymph node and pretreatment serum Epstein-Barr virus DNA copy number in predicting distant metastasis in patients with N1 nasopharyngeal carcinoma.
Yao JJ; Zhou GQ; Wang YQ; Wang SY; Zhang WJ; Jin YN; Zhang F; Li L; Liu LZ; Cheng ZB; Ma J; Qi ZY; Sun Y
Chin J Cancer; 2017 Dec; 36(1):98. PubMed ID: 29284539
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of plasma Epstein-Barr virus DNA level during posttreatment follow-up in the patients with nasopharyngeal carcinoma having undergone intensity-modulated radiotherapy.
Li WF; Zhang Y; Huang XB; Du XJ; Tang LL; Chen L; Peng H; Guo R; Sun Y; Ma J
Chin J Cancer; 2017 Nov; 36(1):87. PubMed ID: 29116021
[TBL] [Abstract][Full Text] [Related]
15. Associations Between Dynamic Contrast Enhanced Magnetic Resonance Imaging and Clinically Relevant Histopathological Features in Breast Cancer: A Multicenter Analysis.
Surov A; Kim JY; Aiello M; Huang W; Yankeelov TE; Wienke A; Pech M
In Vivo; 2022; 36(1):398-408. PubMed ID: 34972741
[TBL] [Abstract][Full Text] [Related]
16. Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma.
Guo R; Tang LL; Mao YP; Du XJ; Chen L; Zhang ZC; Liu LZ; Tian L; Luo XT; Xie YB; Ren J; Sun Y; Ma J
Cancer; 2019 Jan; 125(1):79-89. PubMed ID: 30351466
[TBL] [Abstract][Full Text] [Related]
17. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
[TBL] [Abstract][Full Text] [Related]
18. Dynamic Contrast-Enhanced Magnetic Resonance Imaging of Regional Nodal Metastasis in Nasopharyngeal Carcinoma: Correlation with Nodal Staging.
Huang B; Kwong DL; Lai V; Chan Q; Whitcher B; Khong PL
Contrast Media Mol Imaging; 2017; 2017():4519653. PubMed ID: 29097922
[TBL] [Abstract][Full Text] [Related]
19. Differential diagnosis of nasopharyngeal carcinoma and nasopharyngeal lymphoma based on DCE-MRI and RESOLVE-DWI.
Song C; Cheng P; Cheng J; Zhang Y; Sun M; Xie S; Zhang X
Eur Radiol; 2020 Jan; 30(1):110-118. PubMed ID: 31372786
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of plasma Epstein-Barr Virus DNA loads in a large cohort of Malaysian patients with nasopharyngeal carcinoma.
Chai SJ; Pua KC; Saleh A; Yap YY; Lim PV; Subramaniam SK; Lum CL; Krishnan G; Mahiyuddin WR; ; Teo SH; Khoo AS; Yap LF
J Clin Virol; 2012 Sep; 55(1):34-9. PubMed ID: 22739102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
